Icahn School of Medicine at Mount Sinai: Hepatitis C trials

The registry lists 12 Hepatitis C studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 2Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related CryoglobulinemiaCompletedNCT02825212Phase 2/3Results posted
• Eliminating Hepatitis C VirusCompletedNCT03401697
• Hepatitis C Infection in World Trade Center RespondersCompletedNCT02982993
• Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) ScreeningCompletedNCT02833298Not applicable
• Evaluation of HepCure Toolkit to Improve Harvoni AdherenceCompletedNCT02740556Not applicable
• Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in BloodCompletedNCT02718573
• Biomarkers of Liver FibrosisTerminatedNCT02438917
• Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related QualityCompletedNCT02427204
• Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV CoinfectionCompletedNCT02294136Not applicable
• Prevention of Depression in HIV/HCV Co-infected Substance Abuse PatientsTerminatedNCT00655226Not applicable
• Effects of HIV and Hepatitis C Virus on the BrainCompletedNCT00494936
• Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-DrinkersCompletedNCT00211848Phase 2